November 13, 2024

Respiratory Disease Vaccine Market Size to Garner USD 116.53 Billion by 2032

The global Respiratory disease vaccine market size was estimated to be around US$ 116.53  billion in 2022. It is projected to reach US$ 116.53 billion by 2032, indicating a CAGR of 2.05% from 2023 to 2032.

Respiratory Disease Vaccine Market Size 2023 To 2032

Key Takeaways

  • Asia Pacific dominated the market in 2022 with the largest market share of 55% in 2022.
  • By Distribution Channel, the hospital segment dominated the market with the highest market of 55% in 2022.
  • By Disease Type, the chronic obstructive pulmonary disease (COPD) segment dominated the market in 2022.
  • By Type, the viral vaccine segment contributed more than 55% of revenue share in 2022.
  •  By Type, the bacterial vaccine segment is expected to expand at a significant CAGR during the forecast period.
  • By Age Group, the adult segment dominated the market with a major market share of 77% in 2022.
  • By Age Group, the pediatric segment is expected to be the most lucrative segment of the market throughout the forecast period.
  • By Infection, the COVID-19 segment captured more than 70% of market share in 2022.
  • By Infection, the Respiratory Syncytial Virus (RSV) segment is expected to grow at a significant rate during the forecast period.

The market research report on the Respiratory disease vaccine market provides a comprehensive analysis of various key aspects. It includes the definition, classification, and application of Respiratory disease vaccine products. The report examines the development trends, competitive landscape, and industrial chain structure within the industry. Furthermore, it presents an overview of the industry, analyzes national policies and planning, and offers insights into the latest market dynamics and opportunities at a global level.

Get a Sample: https://www.precedenceresearch.com/sample/3249

Report Scope of the Respiratory Disease Vaccine Market:

Report Coverage Details
Market Size in 2023 USD 97.08 Billion
Market Size by 2032 USD 116.53 Billion
Growth Rate from 2023 to 2032 CAGR of 2.05%
Largest Market Asia Pacific
Base Year 2022
Forecast Period 2023 To 2032
Segments Covered By Disease Type, By Type, By Age Group, and By Infection, By Distribution Channel
Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Read More: Chip Resistor Market Size to Garner USD 3.7 Billion by 2032

The report presents the volume and value-based market size for the base year 2022 and forecasts the market’s growth between 2023 and 2032. It estimates market numbers based on product form and application, providing size and forecast for each application segment in both global and regional markets.

Focusing on the global Respiratory disease vaccine market, the report highlights its status, future forecasts, growth opportunities, key market players, and key market regions such as the United States, Europe, and China. The study aims to present the development of the Respiratory disease vaccine market by considering factors like Year-on-Year (Y-o-Y) growth, in addition to Compound Annual Growth Rate (CAGR). This approach enables a better understanding of market certainty and the identification of lucrative opportunities.

Regarding production, the report investigates the capacity, production, value, ex-factory price, growth rate, and market share of major manufacturers, regions, and product types. On the consumption side, the report focuses on the regional consumption of Respiratory disease vaccine products across different countries and applications.

Buyers of the report gain access to verified market figures, including global market size in terms of revenue and volume. The report provides reliable estimations and calculations for global revenue and volume by product type from 2023 to 2032. It also includes accurate figures for production capacity and production by region during the same period.

The research includes product parameters, production processes, cost structures, and data classified by region, technology, and application. Furthermore, it conducts SWOT analysis and investment feasibility studies for new projects.

This in-depth research report offers valuable insights into the Respiratory disease vaccine market. It employs an objective and fair approach to analyze industry trends, supporting customer competition analysis, development planning, and investment decision-making. The project received support and assistance from technicians and marketing personnel across various links in the industry chain.

The competitive landscape section of the report provides detailed information on Respiratory disease vaccine market competitors. It includes company overviews, financials, revenue generation, market potential, research and development investments, new market initiatives, global presence, production sites, production capacities, strengths and weaknesses, product launches, product range, and application dominance. However, the data points provided only focus on the companies’ activities related to the Respiratory disease vaccine market.

Prominent players in the market are expected to face tough competition from new entrants. Key players are targeting acquisitions of startup companies to maintain their dominance. The report

Reasons to Purchase this Report:

  • Comprehensive market segmentation analysis incorporating qualitative and quantitative research, considering the impact of economic and policy factors.
  • In-depth regional and country-level analysis, examining the demand and supply dynamics that influence market growth.
  • Market size in USD million and volume in million units provided for each segment and sub-segment.
  • Detailed competitive landscape, including market share of major players, recent projects, and strategies implemented over the past five years.
  • Comprehensive company profiles encompassing product offerings, key financial information, recent developments, SWOT analysis, and employed strategies by major market players.

Key Market Players:

  • Sanofi
  • GSK plc
  • Merck & Co., Inc.
  • Pfizer Inc.
  • Bavarian Nordic
  • EMERGENT
  • CSL Limited
  • Moderna, Inc.
  • Serum Institute of India Pvt. Ltd.
  • Sinovac Biotech

Segments Covered in the Report:

By Disease Type

  • Chronic Obstructive Pulmonary Disease (COPD)
  • Pertussis
  • Pneumonia
  • Measles
  • Diphtheria

By Type

  • Viral Vaccine
  • Bacterial Vaccine
  • Combination Vaccine

By Age Group

  • Pediatric
  • Adult

By Infection

  • COVID-19
  • Influenza
  • Respiratory Syncytial Virus (RSV)
  • Pneumonia
  • Others

By Distribution Channel

  • Hospital & Retail Pharmacies
  • Government Suppliers
  • Others

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Respiratory Disease Vaccine Market 

5.1. COVID-19 Landscape: Respiratory Disease Vaccine Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Respiratory Disease Vaccine Market, By Disease Type

8.1. Respiratory Disease Vaccine Market Revenue and Volume, by Disease Type, 2023-2032

8.1.1. Chronic Obstructive Pulmonary Disease (COPD)

8.1.1.1. Market Revenue and Volume Forecast (2020-2032)

8.1.2. Pertussis

8.1.2.1. Market Revenue and Volume Forecast (2020-2032)

8.1.3. Pneumonia

8.1.3.1. Market Revenue and Volume Forecast (2020-2032)

8.1.4. Measles

8.1.4.1. Market Revenue and Volume Forecast (2020-2032)

8.1.5. Diphtheria

8.1.5.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 9. Global Respiratory Disease Vaccine Market, By Type

9.1. Respiratory Disease Vaccine Market Revenue and Volume, by Type, 2023-2032

9.1.1. Viral Vaccine

9.1.1.1. Market Revenue and Volume Forecast (2020-2032)

9.1.2. Bacterial Vaccine

9.1.2.1. Market Revenue and Volume Forecast (2020-2032)

9.1.3. Combination Vaccine

9.1.3.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 10. Global Respiratory Disease Vaccine Market, By Age Group 

10.1. Respiratory Disease Vaccine Market Revenue and Volume, by Age Group, 2023-2032

10.1.1. Pediatric

10.1.1.1. Market Revenue and Volume Forecast (2020-2032)

10.1.2. Adult

10.1.2.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 11. Global Respiratory Disease Vaccine Market, By Infection

11.1. Respiratory Disease Vaccine Market Revenue and Volume, by Infection, 2023-2032

11.1.1. COVID-19

11.1.1.1. Market Revenue and Volume Forecast (2020-2032)

11.1.2. Influenza

11.1.2.1. Market Revenue and Volume Forecast (2020-2032)

11.1.3. Respiratory Syncytial Virus (RSV)

11.1.3.1. Market Revenue and Volume Forecast (2020-2032)

11.1.4. Pneumonia

11.1.4.1. Market Revenue and Volume Forecast (2020-2032)

11.1.5. Others

11.1.5.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 12. Global Respiratory Disease Vaccine Market, By Distribution Channel

12.1. Respiratory Disease Vaccine Market Revenue and Volume, by Distribution Channel, 2023-2032

12.1.1. Hospital & Retail Pharmacies

12.1.1.1. Market Revenue and Volume Forecast (2020-2032)

12.1.2. Government Suppliers

12.1.2.1. Market Revenue and Volume Forecast (2020-2032)

12.1.3. Others

12.1.3.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 13. Global Respiratory Disease Vaccine Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Volume Forecast, by Disease Type (2020-2032)

13.1.2. Market Revenue and Volume Forecast, by Type (2020-2032)

13.1.3. Market Revenue and Volume Forecast, by Age Group (2020-2032)

13.1.4. Market Revenue and Volume Forecast, by Infection (2020-2032)

13.1.5. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)

13.1.6. U.S.

13.1.6.1. Market Revenue and Volume Forecast, by Disease Type (2020-2032)

13.1.6.2. Market Revenue and Volume Forecast, by Type (2020-2032)

13.1.6.3. Market Revenue and Volume Forecast, by Age Group (2020-2032)

13.1.6.4. Market Revenue and Volume Forecast, by Infection (2020-2032)

13.1.6.5. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Volume Forecast, by Disease Type (2020-2032)

13.1.7.2. Market Revenue and Volume Forecast, by Type (2020-2032)

13.1.7.3. Market Revenue and Volume Forecast, by Age Group (2020-2032)

13.1.7.4. Market Revenue and Volume Forecast, by Infection (2020-2032)

13.1.7.5. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)

13.2. Europe

13.2.1. Market Revenue and Volume Forecast, by Disease Type (2020-2032)

13.2.2. Market Revenue and Volume Forecast, by Type (2020-2032)

13.2.3. Market Revenue and Volume Forecast, by Age Group (2020-2032)

13.2.4. Market Revenue and Volume Forecast, by Infection (2020-2032)

13.2.5. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)

13.2.6. UK

13.2.6.1. Market Revenue and Volume Forecast, by Disease Type (2020-2032)

13.2.6.2. Market Revenue and Volume Forecast, by Type (2020-2032)

13.2.6.3. Market Revenue and Volume Forecast, by Age Group (2020-2032)

13.2.7. Market Revenue and Volume Forecast, by Infection (2020-2032)

13.2.8. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)

13.2.9. Germany

13.2.9.1. Market Revenue and Volume Forecast, by Disease Type (2020-2032)

13.2.9.2. Market Revenue and Volume Forecast, by Type (2020-2032)

13.2.9.3. Market Revenue and Volume Forecast, by Age Group (2020-2032)

13.2.10. Market Revenue and Volume Forecast, by Infection (2020-2032)

13.2.11. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)

13.2.12. France

13.2.12.1. Market Revenue and Volume Forecast, by Disease Type (2020-2032)

13.2.12.2. Market Revenue and Volume Forecast, by Type (2020-2032)

13.2.12.3. Market Revenue and Volume Forecast, by Age Group (2020-2032)

13.2.12.4. Market Revenue and Volume Forecast, by Infection (2020-2032)

13.2.13. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Volume Forecast, by Disease Type (2020-2032)

13.2.14.2. Market Revenue and Volume Forecast, by Type (2020-2032)

13.2.14.3. Market Revenue and Volume Forecast, by Age Group (2020-2032)

13.2.14.4. Market Revenue and Volume Forecast, by Infection (2020-2032)

13.2.15. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)

13.3. APAC

13.3.1. Market Revenue and Volume Forecast, by Disease Type (2020-2032)

13.3.2. Market Revenue and Volume Forecast, by Type (2020-2032)

13.3.3. Market Revenue and Volume Forecast, by Age Group (2020-2032)

13.3.4. Market Revenue and Volume Forecast, by Infection (2020-2032)

13.3.5. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)

13.3.6. India

13.3.6.1. Market Revenue and Volume Forecast, by Disease Type (2020-2032)

13.3.6.2. Market Revenue and Volume Forecast, by Type (2020-2032)

13.3.6.3. Market Revenue and Volume Forecast, by Age Group (2020-2032)

13.3.6.4. Market Revenue and Volume Forecast, by Infection (2020-2032)

13.3.7. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)

13.3.8. China

13.3.8.1. Market Revenue and Volume Forecast, by Disease Type (2020-2032)

13.3.8.2. Market Revenue and Volume Forecast, by Type (2020-2032)

13.3.8.3. Market Revenue and Volume Forecast, by Age Group (2020-2032)

13.3.8.4. Market Revenue and Volume Forecast, by Infection (2020-2032)

13.3.9. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)

13.3.10. Japan

13.3.10.1. Market Revenue and Volume Forecast, by Disease Type (2020-2032)

13.3.10.2. Market Revenue and Volume Forecast, by Type (2020-2032)

13.3.10.3. Market Revenue and Volume Forecast, by Age Group (2020-2032)

13.3.10.4. Market Revenue and Volume Forecast, by Infection (2020-2032)

13.3.10.5. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Volume Forecast, by Disease Type (2020-2032)

13.3.11.2. Market Revenue and Volume Forecast, by Type (2020-2032)

13.3.11.3. Market Revenue and Volume Forecast, by Age Group (2020-2032)

13.3.11.4. Market Revenue and Volume Forecast, by Infection (2020-2032)

13.3.11.5. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)

13.4. MEA

13.4.1. Market Revenue and Volume Forecast, by Disease Type (2020-2032)

13.4.2. Market Revenue and Volume Forecast, by Type (2020-2032)

13.4.3. Market Revenue and Volume Forecast, by Age Group (2020-2032)

13.4.4. Market Revenue and Volume Forecast, by Infection (2020-2032)

13.4.5. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)

13.4.6. GCC

13.4.6.1. Market Revenue and Volume Forecast, by Disease Type (2020-2032)

13.4.6.2. Market Revenue and Volume Forecast, by Type (2020-2032)

13.4.6.3. Market Revenue and Volume Forecast, by Age Group (2020-2032)

13.4.6.4. Market Revenue and Volume Forecast, by Infection (2020-2032)

13.4.7. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)

13.4.8. North Africa

13.4.8.1. Market Revenue and Volume Forecast, by Disease Type (2020-2032)

13.4.8.2. Market Revenue and Volume Forecast, by Type (2020-2032)

13.4.8.3. Market Revenue and Volume Forecast, by Age Group (2020-2032)

13.4.8.4. Market Revenue and Volume Forecast, by Infection (2020-2032)

13.4.9. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)

13.4.10. South Africa

13.4.10.1. Market Revenue and Volume Forecast, by Disease Type (2020-2032)

13.4.10.2. Market Revenue and Volume Forecast, by Type (2020-2032)

13.4.10.3. Market Revenue and Volume Forecast, by Age Group (2020-2032)

13.4.10.4. Market Revenue and Volume Forecast, by Infection (2020-2032)

13.4.10.5. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Volume Forecast, by Disease Type (2020-2032)

13.4.11.2. Market Revenue and Volume Forecast, by Type (2020-2032)

13.4.11.3. Market Revenue and Volume Forecast, by Age Group (2020-2032)

13.4.11.4. Market Revenue and Volume Forecast, by Infection (2020-2032)

13.4.11.5. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)

13.5. Latin America

13.5.1. Market Revenue and Volume Forecast, by Disease Type (2020-2032)

13.5.2. Market Revenue and Volume Forecast, by Type (2020-2032)

13.5.3. Market Revenue and Volume Forecast, by Age Group (2020-2032)

13.5.4. Market Revenue and Volume Forecast, by Infection (2020-2032)

13.5.5. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)

13.5.6. Brazil

13.5.6.1. Market Revenue and Volume Forecast, by Disease Type (2020-2032)

13.5.6.2. Market Revenue and Volume Forecast, by Type (2020-2032)

13.5.6.3. Market Revenue and Volume Forecast, by Age Group (2020-2032)

13.5.6.4. Market Revenue and Volume Forecast, by Infection (2020-2032)

13.5.7. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Volume Forecast, by Disease Type (2020-2032)

13.5.8.2. Market Revenue and Volume Forecast, by Type (2020-2032)

13.5.8.3. Market Revenue and Volume Forecast, by Age Group (2020-2032)

13.5.8.4. Market Revenue and Volume Forecast, by Infection (2020-2032)

13.5.8.5. Market Revenue and Volume Forecast, by Distribution Channel (2020-2032)

Chapter 14. Company Profiles

14.1. Sanofi

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. GSK plc

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Merck & Co., Inc.

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Pfizer Inc.

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Bavarian Nordic

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. EMERGENT

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. CSL Limited

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Moderna, Inc.

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Serum Institute of India Pvt. Ltd.

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Sinovac Biotech

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://www.expresswebwire.com/

Blog: https://www.uswebwire.com/

Blog: https://www.dailytechbulletin.com/

Blog: https://www.autoindustrybulletin.com/

Prathamesh

I have completed my education in Bachelors in Computer Application. A focused learner having a keen interest in the field of digital marketing, SEO, SMM, and Google Analytics enthusiastic to learn new things along with building leadership skills.

View all posts by Prathamesh →

Leave a Reply

Your email address will not be published. Required fields are marked *